Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person BRCA2 mutants (RAD51 binding):SEM1 [nucleoplasm]
| Class:Id | Complex:9763400 |
|---|---|
| _displayName | BRCA2 mutants (RAD51 binding):SEM1 [nucleoplasm] |
| _timestamp | 2022-02-02 17:57:52 |
| compartment | [Compartment:7660] nucleoplasm |
| created | [InstanceEdit:9763401] Orlic-Milacic, Marija, 2022-02-02 |
| disease | [Disease:1500689] cancer |
| hasComponent | |
| isChimeric | FALSE |
| name | BRCA2 mutants (RAD51 binding):SEM1 BRCA2 mutants (RAD51 binding):DSS1 |
| species | [Species:48887] Homo sapiens |
| stableIdentifier | [StableIdentifier:9763402] R-HSA-9763400.1 |
| (diseaseEntity) | [EntityFunctionalStatus:9763399] loss_of_function of BRCA2 mutants (RAD51 binding):SEM1 [nucleoplasm] |
| (input) | [FailedReaction:9709571] BRCA2 mutants with BRC defects or a defect in the C-terminal RAD51 binding site do not bind RAD51 [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by BRCA2 mutants (RAD51 binding):SEM1 [nucleoplasm] (9763400)
